242 related articles for article (PubMed ID: 797499)
1. Propranolol disposition in chronic liver disease: a physiological approach.
Branch RA; Shand DG
Clin Pharmacokinet; 1976; 1(4):264-79. PubMed ID: 797499
[TBL] [Abstract][Full Text] [Related]
2. A study of factors influencing drug disposition in chronic liver disease, using the model drug (+)-propranolol.
Branch RA; James J; Read AE
Br J Clin Pharmacol; 1976 Apr; 3(2):243-9. PubMed ID: 973958
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive kinetic approach to the estimation of total hepatic blood flow and shunting in chronic liver disease--a hypothesis.
McLean A; du Souich P; Gibaldi M
Clin Pharmacol Ther; 1979 Feb; 25(2):161-6. PubMed ID: 759068
[TBL] [Abstract][Full Text] [Related]
4. Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.
Evans GH; Shand DG
Clin Pharmacol Ther; 1973; 14(4):494-500. PubMed ID: 4723256
[No Abstract] [Full Text] [Related]
5. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
Wells PG; Feely J; Wilkinson GR; Wood AJ
Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
[TBL] [Abstract][Full Text] [Related]
6. Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.
Lo MW; Pond SM; Effeney DJ; Silber BM; Riegelman S; Tozer TN
J Pharmacokinet Biopharm; 1984 Aug; 12(4):401-12. PubMed ID: 6527232
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic drug interactions with propranolol.
Wood AJ; Feely J
Clin Pharmacokinet; 1983; 8(3):253-62. PubMed ID: 6342901
[TBL] [Abstract][Full Text] [Related]
8. Effects of age and cigarette smoking on propranolol disposition.
Vestal RE; Wood AJ; Branch RA; Shand DG; Wilkinson GR
Clin Pharmacol Ther; 1979 Jul; 26(1):8-15. PubMed ID: 445965
[No Abstract] [Full Text] [Related]
9. Clearance by the liver in cirrhosis. III. Propranolol uptake by the isolated perfused human liver.
Villeneuve JP; Dagenais M; Huet PM; Lapointe R; Roy A; Marleau D
Can J Physiol Pharmacol; 1996 Dec; 74(12):1327-32. PubMed ID: 9047043
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of propranolol: a review.
Shand DG
Postgrad Med J; 1976; 52 Suppl 4():22-25. PubMed ID: 787953
[TBL] [Abstract][Full Text] [Related]
11. Propranolol disposition in renal failure.
Wood AJ; Vestal RE; Spannuth CL; Stone WJ; Wilkinson GR; Shand DG
Br J Clin Pharmacol; 1980 Dec; 10(6):561-6. PubMed ID: 7470370
[TBL] [Abstract][Full Text] [Related]
12. Disposition of propranolol. V. Drug accumulation and steady-state concentrations during chronic oral administration in man.
Evans GH; Shand DG
Clin Pharmacol Ther; 1973; 14(4):487-93. PubMed ID: 4723255
[No Abstract] [Full Text] [Related]
13. Protein binding and kinetics of drugs in liver diseases.
Blaschke TF
Clin Pharmacokinet; 1977; 2(1):32-44. PubMed ID: 322909
[TBL] [Abstract][Full Text] [Related]
14. Commentary: a physiological approach to hepatic drug clearance.
Wilkinson GR; Shand DG
Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
[TBL] [Abstract][Full Text] [Related]
15. Drug disposition and liver disease.
Wilkinson GR; Schenker S
Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
[No Abstract] [Full Text] [Related]
16. [Effect of portasystemic anastomoses in childhood on propranolol pharmacokinetics].
Cario WR; Glende M; Lampe D; Buchali K; Bürger K; Grossmann P; Huth M; Rüstow B; Zimmermann HB
Schweiz Med Wochenschr; 1981 Jul; 111(29):1088-93. PubMed ID: 7268362
[TBL] [Abstract][Full Text] [Related]
17. Clinical pharmacokinetics of propranolol.
Routledge PA; Shand DG
Clin Pharmacokinet; 1979; 4(2):73-90. PubMed ID: 378502
[TBL] [Abstract][Full Text] [Related]
18. The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administration.
Wood AJ; Kornhauser DM; Wilkinson GR; Shand DG; Branch RA
Clin Pharmacokinet; 1978; 3(6):478-87. PubMed ID: 719984
[No Abstract] [Full Text] [Related]
19. Effect of age on the hepatic clearance of propranolol in rats.
Iwamoto K; Watanabe J; Araki K; Deguchi N; Sugiyama H
J Pharm Pharmacol; 1985 Jul; 37(7):466-70. PubMed ID: 2863348
[TBL] [Abstract][Full Text] [Related]
20. The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.
Evans GH; Nies AS; Shand DG
J Pharmacol Exp Ther; 1973 Jul; 186(1):114-22. PubMed ID: 4198771
[No Abstract] [Full Text] [Related]
[Next] [New Search]
